Factors associated with drug-resistant epilepsy in adults from Southern Kazakhstan.
Overview
- Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkistan, Kazakhstan
- South Kazakhstan Medical Academy, Shymkent, Kazakhstan
Abstract
Introduction: The prevalence of drug-resistant epilepsy (DRE) among epilepsy patients has not decreased despite better diagnostic methods and treatment options because it affects approximately one-third of all epilepsy patients. The research aims to identify which clinical patterns and social characteristics contribute to drug resistance.
Methods: This retrospective analytical cross-sectional study included 300 patients with epilepsy in Southern Kazakhstan. The participants received their drug resistance status through ILAE criteria, which classified them into drug-sensitive (DSE) or drug-resistant groups. Patient data was studied through clinical and socio-demographic evaluations, EEG and MRI assessments, and MoCA cognitive performance tests.
Results: The research discovered drug-resistant epilepsy in 37% of participants. The DRE patients were 35 ± 12 years old at the time of study, while DSE patients were 39 ± 15 years old (p = 0.023). The development of DRE became more likely when patients experienced their first seizure at a young age and when they had multiple seizures throughout the day (p < 0.01). The presence of MRI abnormalities increased the risk of drug resistance by 2.42 times (95% CI: 1.3–4.23) when compared to drug-sensitive epilepsy patients (p = 0.002).
Conclusion: The study revealed that early seizure onset, prolonged duration, severe seizures, brain imaging abnormalities, and lower cognitive performance are related to DRE.
Reproduced under the paper's license (CC BY-NC), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- figshare:32132798, at figshare; found in DataCite
Data availability statement
The data that support the findings of this study are available on request from the corresponding author, N.N. The data are not publicly available due to privacy reasons.
Reproduced under the paper's license (CC BY-NC), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 30 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 12 authors, 5 keywords, 1 funder, 42 references.
Cite
This paper
Baimakhanova, G., Nurdinov, N., Nuskabayeva, G., Zharkinbekova, N., Sadykova, K., Skenderova, A., Gencer, M. Z., Doszhanov, I., Yerkhojayeva, N., Anarbayeva, A., Skenderova, S., & Kaldarkhan, D. (2026). Factors associated with drug-resistant epilepsy in adults from Southern Kazakhstan. Future science OA, 12(1), 2665757. https://
BibTeX
@article{baimakhanova202
author = {Baimakhanova, Gulzira and Nurdinov, Nursultan and Nuskabayeva, Gulnaz and Zharkinbekova, Nazira and Sadykova, Karlygash and Skenderova, Akbota and Gencer, Mehmet Ziya and Doszhanov, Islamkhan and Yerkhojayeva, Nigara and Anarbayeva, Assel and Skenderova, Shakhista and Kaldarkhan, Dana},
title = {{Factors associated with drug-resistant epilepsy in adults from Southern Kazakhstan}},
journal = {Future science OA},
year = {2026},
month = apr,
volume = {12},
number = {1},
pages = {2665757},
publisher = {Taylor \& Francis},
issn = {2056-5623},
doi = {10.1080/
url = {https://
pmid = {42057682},
pmcid = {PMC13134400}
}
RIS
TY - JOUR
AU - Baimakhanova, Gulzira
AU - Nurdinov, Nursultan
AU - Nuskabayeva, Gulnaz
AU - Zharkinbekova, Nazira
AU - Sadykova, Karlygash
AU - Skenderova, Akbota
AU - Gencer, Mehmet Ziya
AU - Doszhanov, Islamkhan
AU - Yerkhojayeva, Nigara
AU - Anarbayeva, Assel
AU - Skenderova, Shakhista
AU - Kaldarkhan, Dana
TI - Factors associated with drug-resistant epilepsy in adults from Southern Kazakhstan
T2 - Future science OA
J2 - Future Sci OA
PY - 2026
DA - 2026/
VL - 12
IS - 1
SP - 2665757
SN - 2056-5623
PB - Taylor & Francis
DO - 10.1080/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1080/
"type": "article-journal",
"title": "Factors associated with drug-resistant epilepsy in adults from Southern Kazakhstan",
"container-title": "Future science OA",
"author": [
{
"family": "Baimakhanova",
"given": "Gulzira"
},
{
"family": "Nurdinov",
"given": "Nursultan"
},
{
"family": "Nuskabayeva",
"given": "Gulnaz"
},
{
"family": "Zharkinbekova",
"given": "Nazira"
},
{
"family": "Sadykova",
"given": "Karlygash"
},
{
"family": "Skenderova",
"given": "Akbota"
},
{
"family": "Gencer",
"given": "Mehmet Ziya"
},
{
"family": "Doszhanov",
"given": "Islamkhan"
},
{
"family": "Yerkhojayeva",
"given": "Nigara"
},
{
"family": "Anarbayeva",
"given": "Assel"
},
{
"family": "Skenderova",
"given": "Shakhista"
},
{
"family": "Kaldarkhan",
"given": "Dana"
}
],
"container-title-short":
"volume": "12",
"issue": "1",
"page": "2665757",
"DOI": "10.1080/
"PMID": "42057682",
"PMCID": "PMC13134400",
"ISSN": "2056-5623",
"publisher": "Taylor & Francis",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
30
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1186/s12883-026-04944-z
- CACNA1A c.5610del in a three-generation family: epilepsy with ataxia/
migraine. Journal: BMC neurologyIn common: epilepsy, clinical / translational, 2 references - [2] doi:10.3389/fncel.2025.1572213
- Sex-specific interneuron vulnerability after traumatic brain injury correlates with neurotrophic signaling and chloride homeostasis, independent of behavioral and network outcomes.Journal: Frontiers in cellular neuroscienceIn common: 2 references
- [3] doi:10.1038/s41598-025-00986-4
- A transcriptomic and proteomic analysis and comparison of human brain tissue from patients with and without epilepsy.Journal: Scientific reportsIn common: epilepsy, clinical / translational, 1 reference
- [4] doi:10.1002/jmri.29663 [code]
- Seizure Burden and Clinical Risk Factors in Glioma-Related Epilepsy: Insights From MRI Voxel-Based Lesion-Symptom Mapping.Journal: Journal of magnetic resonance imaging : JMRIIn common: epilepsy, clinical / translational, 1 reference
- [5] doi:10.1136/bmjopen-2021-059301
- Real-time seizure detection in paediatric intensive care patients: the RESET child brain protocol.Journal: BMJ openIn common: epilepsy, clinical / translational, 1 reference
- [6] doi:10.1038/s41598-026-38981-y [code]
- Pseudo-healthy image synthesis via location-guided diffusion models for focal cortical dysplasia lesion localization.Journal: Scientific reportsIn common: epilepsy, clinical / translational, 1 reference
- [7] doi:10.3389/fmicb.2025.1630062
- Multi-omics integration reveals gut microbiota dysbiosis and metabolic alterations of cerebrospinal fluid in children with epilepsy.Journal: Frontiers in microbiologyIn common: epilepsy, clinical / translational, 1 reference
- [8] doi:10.1002/epi4.12834
- Bilateral ictal EEG is associated with better memory outcome after hippocampal sclerosis surgery.Journal: Epilepsia openIn common: epilepsy, clinical / translational, 1 reference
- [9] doi:10.1038/s41598-026-44063-w [code]
- Neuronal silence as a predictive biomarker and target for epileptic seizures suppression.Journal: Scientific reportsIn common: epilepsy, clinical / translational, 1 reference
- [10] doi:10.1159/000548718
- Hemispherotomy for Drug-Resistant Epilepsy in a Low-Resource Setting: Surgical Outcomes and Quality of Life in 23 Children Treated in a Hybrid Program in Panama.Journal: Pediatric neurosurgeryIn common: epilepsy, clinical / translational, 1 reference
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
